查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1844408

生物影像市场按技术、产品、模式、应用和最终用户划分－2025-2032年全球预测

Bio-imaging Market by Technology, Product, Modality, Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，生物成像市场规模将成长 149 亿美元，复合年增长率为 10.50%。

主要市场统计数据
基准年 2024 67亿美元
预计年份：2025年 73.8亿美元
预测年份：2032年 149亿美元
复合年增长率 (%) 10.50%

本书清晰权威地阐述了成像技术、分析技术和临床工作流程的整合如何重塑诊断准确性和研究管道。

生物影像领域正经历重大变革，硬体、软体和临床整合的同步进步推动着这项变革。曾经各自独立应用于诊断和手术的影像方式逐渐融合，形成以诊断准确性、工作流程效率和资料互通性为优先的混合工作流程。临床医生和研究人员都越来越重视影像衍生分析、纵向资料撷取和可重复的影像通讯协定，以支持个人化医疗和转化研究。

在此背景下，对影像分析软体、云端原生资料管理和设备互通性的投资正在改变终端用户的采购重点。这些转变并非仅仅是技术层面的；它们反映了临床管道的变化，即影像技术更紧密地融入治疗决策和药物研发流程。因此，製造商和解决方案提供者必须调整其创新策略，以适应不断变化的临床医生需求、监管预期以及支付方对临床价值的论证主导。本文的概要将阐述上述执行摘要，并为深入探讨市场动态、政策影响、细分市场细微差别、区域差异以及为引领这一快速发展行业的领导者提供的建议行动奠定基础。

人工智慧整合、模态混合、云端协作和流程分散化如何重新定义生物成像的临床工作流程和商业化模式

影像产业正经历一场变革性的转变，这场转变不仅体现在产品的渐进式改进上，也体现在影像操作、分析和报销方式的系统性变革上。人工智慧和机器学习已从概念验证模型发展成为嵌入式工具，能够增强放射科医生的工作流程，自动化常规影像处理任务，并挖掘具有临床意义的生物标记。因此，模型检验、监管核准管道以及如何将人工智慧输出整合到临床决策支援系统中的策略，正日益受到关注。

同时，越来越多的影像模式融合——例如内视镜结合超音波结合造影造影和人工智慧解读——正在拓展整个专科的临床效用。云端基础的资料管理和安全的联邦学习方法正在推动多中心协作，而边缘运算则促进了在患者附近进行照护现场诊断的推理。仪器小型化和手术显微镜的进步正在将手术从住院转移到门诊病人和流动诊疗环境中，从而改变采购週期和资本规划。所有这些转变共同要求相关人员采用灵活的商业化模式，投资于监管和循证能力建设，并建立连接硬体、软体和临床服务的伙伴关係。

评估2025年贸易政策变化对供应链韧性、区域製造策略以及各相关人员采购决策的策略影响

2025年的关税政策为全球成像硬体、组件和耗材的供应链和采购决策带来了新的复杂性。更高的进口关税和贸易政策调整可能会增加依赖国际采购零件的系统的到岸成本，从而增加製造商重新评估其供应商布局和製造地的压力。为此，许多公司正在加快供应商多元化进程，并寻找合格的替代组件来源，以维持生产的连续性和利润率。

关税不仅直接影响成本，还会影响企业在在地化、库存策略以及与客户的价格透明度等方面的策略选择。一些供应商正在评估区域组装和生产线末端製造方案，以减轻关税的影响；而另一些供应商则在协商长期供应商协议，以确保优先获得受限零件。此外，随着企业寻求优化关税待遇并利用贸易便利化机制，监管合规和关税分类变得癒合重要。随着企业适应日益细分且对政策更加敏感的贸易环境，它们正在重新调整采购计划、资本配置和伙伴关係策略。

将机会与特定模式的创新、产品组合、应用需求和最终用户购买行为联繫起来的策略性细分洞察

細項分析揭示了技术、产品、模式、应用和最终用户等维度上的创新与机会的交会点。在技​​术方面，磁振造影和X光成像等成熟模式仍是诊断的核心，而内视镜、核子医学影像、手术显微镜和超音波则随着解析度、便携性和整合性的提升，不断拓展其临床应用范围。这种技术多样性要求供应商根据特定模式的临床工作流程和报销动态，量身订做提案主张。

产品细分錶明，儘管成像系统和仪器仍然是资本支出决策的核心，但试剂和软体作为经常性收入的驱动因素和差异化临床结果的实现者，其重要性日益凸显。在设备方面，CT扫描仪、 核磁共振造影系统和超音波设备具有不同的采购週期和服务模式，这会影响整体拥有成本的计算。软体大致可分为两类：一类是解决互通性和安全性问题的资料管理平台，另一类是提供分析洞察的影像分析工具。这两类软体在供应商差异化中扮演越来越重要的角色。二维和三维成像模式之间的差异凸显了影像撷取、储存和解读方面的不同需求，尤其是在临床诊断、药物研发、研究和治疗领域。最终用户，例如门诊手术中心、影像中心以及医院和诊所，对吞吐量、资本支出和电子健康记录整合等方面的优先顺序各不相同，这影响着他们的采购标准和售后服务期望。透过临床工作流程和采购行为来解读产品细分，可以帮助企业更好地将产品蓝图和商业模式与特定的需求驱动因素相匹配。

美洲、欧洲、中东和非洲以及亚太地区的策略动态和差异化应用模式将体现在量身订製的商业化和监管策略中。

区域动态将显着影响美洲、欧洲、中东和非洲以及亚太地区的采用模式、监管路径和商业性策略。在美洲，受医院整合以及对门诊病人和流动医疗设施投资增加的推动，医疗系统对先进诊断能力和软体驱动的主导提升表现出强烈的需求。在这种环境下，能够展现临床效果和营运成本节约的整合解决方案更受青睐，而报销动态和监管考量将决定采用速度。

中东和非洲市场的监管环境、国家医疗保健重点和基础设施的差异正在影响打入市场策略。一些市场强调集中式、高品质的影像中心和国家筛检项目，从而推动了对可扩展、可互通解决方案的需求。另一些市场则投资于扩大和现代化生产能力，为模组化系统和远端服务交付创造了机会。亚太地区的特点是诊断基础设施的快速扩张、对本地製造的投资以及对高性价比高性能技术的重视。私人医疗保健的成长和旨在改善诊断可及性的公共倡议正在推动对高端和可携式即时检测（POC​​）设备的需求。成功的商业化需要在地化的服务网络、遵守区域监管框架以及进行符合文化背景的临床检验。了解这些区域差异将有助于有针对性地分配资源和选择伙伴关係，从​​而加速市场渗透。

竞争与合作的趋势揭示了现有企业、创新者和软体专家如何透过伙伴关係、併购和证据生成等方式携手合作，在生物成像领域取得成功。

生物成像领域的竞争格局由传统跨国供应商、敏捷的设备创新者和软体专家组成。传统製造商拥有规模优势、庞大的用户装置量的服务网络以及丰富的监管经验，这些优势支撑着大额资本销售和长期服务协议。同时，规模较小的公司和新兴企业正在影像分析、云端原生资料管理和照护现场设备等领域迅速推出颠覆性功能，促使它们透过伙伴关係、授权协议和有针对性的收购来加速自身能力建设。

随着硬体供应商寻求将能够展现可衡量的临床价值的分析和资讯服务捆绑销售，设备原始设备製造商 (OEM) 与软体公司之间的策略合作日益普遍。与学术医疗中心和临床研究机构建立合作关係对于证据产生和监管申报也至关重要。此外，投资于完善的上市后监测、网路安全保障和互通性标准的公司，在与需要安全且审核资料流的医疗保健系统竞争时，将占据有利地位。在竞争激烈的市场环境中，能够制定整合临床检验、监管策略和市场进入灵活性的商业化计划的公司将获得丰厚的回报。

为领导者提供切实可行的策略指导，以加强供应链韧性，加速采用检验的人工智慧技术，并使模组化商业化与当地市场实际情况相符。

产业领导者应采取一系列协调一致的行动，将技术前景转化为永续的商业性优势。首先，实现供应链多元化，并对跨区域的製造合作伙伴进行认证，以降低贸易政策波动和关键零件短缺的风险。其次，优先发展模组化产品设计和服务，以实现更快的升级、更便利的维护和多样化的资金筹措模式，从而满足门诊、诊断中心和医院的采购偏好。第三，加快对检验的人工智慧和分析技术的投资，并专注于可解释性、临床检验和监管合规性，以建立临床医生的信任和支付方的认可。

同时，我们将加强与软体供应商、学术中心和专科服务供应商的策略伙伴关係，共同开发将影像输出与改善患者预后联繫起来的证据。我们将实施健全的资料管治、网路安全和互通性框架，以促进多机构合作并确保云端技术的安全应用。最后，我们将根据当地市场实际情况调整商业化计划，使产品组合、服务模式和报销策略与当地市场实际情况相符。这些措施将有助于我们降低执行风险，加快产品推广速度，并在竞争激烈的市场环境中脱颖而出。

严谨的多方法研究设计，结合了初步访谈、二手证据综合和迭代检验，确保为相关人员提供可靠且可操作的见解。

本研究综合运用了定性和定量相结合的多方法研究途径成果。主要研究包括对临床负责人、采购负责人、技术主管和监管专家进行结构化访谈和情境研讨会，以揭示痛点、推动技术应用和商业性优先事项。次要研究则包括对同侪审查文献、监管申报文件、临床指南和技术白皮书进行系统性回顾，以识别技术趋势和证据要求。

资料三角测量法用于整合不同资讯来源的见解，主题分析则突显了推广过程中反覆出现的障碍和促进因素。与外部专家的验证以及迭代回馈机制确保了结论能够反映相关人员在实际工作中遇到的情况。检验调查方法和资料来源的严谨性透过对资料来源、访谈框架和假设检验的透明记录得以保证，从而确保了研究结果的可重复性和研究建议的可靠性。在主要研究过程中，我们遵循了伦理考量和保密通讯协定，以保护参与者共用的专有资讯。

本文简要概述了整合技术、检验的证据和本地化策略将如何决定生物影像技术在变革临床护理和研究中的价值惠及对象。

摘要：生物成像正处于曲折点，日益精进的技术必须与务实的商业化策略相辅相成。先进影像技术、人工智慧赋能的分析以及云端原生资料架构的融合，在释放新的临床能力的同时，也提高了人们对证据、互通性和资料管理的期望。监管的复杂性和地缘政治贸易动态，增加了策略考量，迫使企业调整供应链、加速临床检验并完善商业模式。

决策者若能果断行动，整合经过检验的软体、模组化硬体和在地化客製化的服务模式，将最有利于创造价值。同样重要的是，他们能够证明可衡量的临床和经济影响。透过将创新蓝图与临床医生的工作流程、支付方的优先事项和当地监管环境相协调，相关人员可以将技术进步转化为可扩展的临床解决方案，从而改善治疗效果并提高营运效率。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

  • 将人工智慧演算法整合到高通量生物成像工作流程中
  • 多模态PET/MRI成像平台的兴起，实现了全面的分子诊断
  • 用于即时活细胞成像应用的超高解析度显微镜技术的进步
  • 推出云端基础的生物成像资料管理解决方案，以实现可扩展的研究协作
  • 促进无标定光学成像技术的发展，以增强快速组织特性分析工作流程
  • 开发用于同步影像和标靶药物传递的诊疗一体化造影造影
  • 将高解析度萤光显微镜与微流体实验室晶片系统集成
  • 采用数位病理学和全切片成像技术可加快癌症诊断和分析速度。

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依技术分類的生物影像市场

  • 内视镜检查
  • 磁振造影
  • 核子造影
  • 手术显微镜
  • 超音波
  • X光影像

第九章 生物影像产品市场

  • 影像系统
  • 装置
    • CT扫描仪
    • 核磁共振造影系统
    • 超音波设备
  • 试剂
  • 软体
    • 资料管理软体
    • 影像分析软体

第十章 生物影像市场依影像方式划分

  • 二维成像
  • 三维成像

第十一章 生物造影市场按应用领域划分

  • 临床诊断
  • 药物发现
  • 研究
  • 治疗

第十二章 生物成像市场（依最终用户划分）

  • 门诊手术中心
  • 诊断影像中心
  • 医院和诊所

第十三章 生物影像市场区域划分

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 生物影像市场（依组别划分）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 各国生物影像市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章 竞争格局

  • 2024年市占率分析
  • FPNV定位矩阵，2024
  • 竞争分析
    • BaySpec, Inc.
    • Bracco SpA
    • Bruker Corporation
    • Canon Medical Systems Corporation
    • Digirad Corporation
    • Esaote SpA
    • Fujifilm Holdings Corporation
    • GE HealthCare Technologies, Inc.
    • Hitachi Medical Corporation
    • HT BioImaging Ltd
    • iThera Medical GmbH
    • Kitware, Inc.
    • Koninklijke Philips NV
    • Lantheus Medical Imaging, Inc.
    • M Squared Lasers Ltd.
    • MARS Bioimaging Limited
    • Medtronic PLC
    • MobileODT Ltd by Liger Medical LLC
    • Perspectum Ltd.
    • Quibim, SL
    • RadNet, Inc.
    • Rivanna Medical, Inc.
    • Samsung Medison Co., Ltd.
    • Siemens Healthineers
Product Code: MRR-710B1F0AC3D1

The Bio-imaging Market is projected to grow by USD 14.90 billion at a CAGR of 10.50% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 6.70 billion
Estimated Year [2025] USD 7.38 billion
Forecast Year [2032] USD 14.90 billion
CAGR (%) 10.50%

A clear and authoritative framing of how convergent imaging technologies, analytics, and clinical workflows are reshaping diagnostic precision and research pathways

The bio-imaging landscape is undergoing a profound evolution driven by parallel advances in hardware, software, and clinical integration. Imaging modalities that were once siloed within diagnostic or surgical contexts are converging into hybrid workflows that prioritize diagnostic precision, workflow efficiency, and data interoperability. Clinicians and researchers alike are placing greater emphasis on image-derived analytics, longitudinal data capture, and reproducible imaging protocols to support personalized care and translational research.

Against this backdrop, investments in image analysis software, cloud-native data management, and device interoperability are reshaping procurement priorities across end users. These shifts are not merely technological; they reflect changing clinical pathways that integrate imaging more tightly into therapeutic decision-making and drug development pipelines. As a result, manufacturers and solution providers must align innovation strategies with evolving clinician needs, regulatory expectations, and payer-driven demands for demonstrable clinical value. This introduction frames the executive summary that follows, setting the stage for detailed discussion of market dynamics, policy impacts, segmentation nuances, regional variations, and recommended actions for leaders navigating this fast-evolving sector.

How AI integration, modality hybridization, cloud-enabled collaboration, and procedural decentralization are jointly redefining clinical workflows and commercialization models in bio-imaging

The industry is experiencing transformative shifts that extend beyond incremental product improvements to systemic changes in how imaging is performed, analyzed, and reimbursed. Artificial intelligence and machine learning have matured from proof-of-concept models into embedded tools that augment radiologist workflows, automate routine image processing tasks, and surface clinically actionable biomarkers. Consequently, attention has turned to model validation, regulatory approval pathways, and strategies to integrate AI outputs into clinical decision support systems.

Simultaneously, hybridization of modalities-where endoscopy is combined with high-resolution imaging, or ultrasound is augmented by contrast agents and AI interpretation-has expanded clinical utility across specialties. Cloud-based data management and secure federated learning approaches are enabling multi-institutional collaboration, while edge computing is facilitating near-patient inference for point-of-care diagnostics. Device miniaturization and advances in surgical microscopy are shifting procedures from inpatient to ambulatory and outpatient settings, altering purchasing cycles and capital planning. Collectively, these shifts demand that stakeholders adopt flexible commercialization models, invest in regulatory and evidence generation capabilities, and form partnerships that bridge hardware, software, and clinical services.

Assessing the strategic implications of 2025 trade policy changes on supply chain resilience, regional manufacturing strategies, and procurement decision-making across imaging stakeholders

The tariff landscape of 2025 has introduced new complexities into global supply chains and procurement decisions for imaging hardware, components, and consumables. Increased import duties and trade policy adjustments have the potential to raise landed costs for systems that rely on internationally sourced components, intensifying pressure on manufacturers to reassess supplier footprints and manufacturing locations. In response, many firms are accelerating supplier diversification and qualifying alternate component sources to sustain production continuity and preserve margin integrity.

Beyond direct cost implications, tariffs influence strategic choices about localization, inventory strategies, and pricing transparency with customers. Some vendors are evaluating regional assembly or final-stage manufacturing to mitigate tariff exposure while others are negotiating long-term supplier agreements to secure priority access to constrained components. Additionally, regulatory compliance and customs classification have become more prominent as companies seek to optimize tariff treatments and leverage trade facilitation mechanisms. The aggregate effect is a recalibration of procurement timelines, capital allocation, and partnership strategies as organizations adapt to a more fragmented and policy-sensitive trade environment.

Strategic segmentation insights that connect modality-specific innovation, product composition, application needs, and end-user procurement behavior to commercial opportunity

Segmentation analysis illuminates where innovation and commercial opportunity intersect across technology, product, modality, application, and end-user dimensions. When considering technology, mature modalities such as magnetic resonance imaging and X-ray imaging continue to be core diagnostic pillars, while endoscopy, nuclear imaging, surgical microscopy, and ultrasound are expanding their clinical reach through enhancements in resolution, portability, and integration. This technological diversity requires vendors to tailor value propositions that align with modality-specific clinical workflows and reimbursement dynamics.

Product segmentation reveals that imaging systems and instruments remain central to capital investment decisions, yet reagents and software are increasingly important as recurring revenue drivers and enablers of differentiated clinical outcomes. Within instruments, CT scanners, MRI machines, and ultrasound devices have distinct procurement cycles and service models that influence total cost of ownership conversations. Software divides broadly into data management platforms that address interoperability and security, and image analysis tools that deliver analytic insights; both categories play a growing role in vendor differentiation. Modality distinctions between 2D and 3D imaging underscore divergent requirements for image acquisition, storage, and interpretation, particularly in applications spanning clinical diagnostics, drug discovery, research, and therapeutics. End users such as ambulatory surgical centers, diagnostic imaging centers, and hospitals and clinics each prioritize different combinations of throughput, capital expense, and integration with electronic health records, shaping purchase criteria and post-sale service expectations. By interpreting segmentation through the lens of clinical workflows and purchasing behavior, organizations can better align product road maps and commercial models to specific demand drivers.

Regional strategic dynamics and differentiated adoption patterns across the Americas, Europe Middle East & Africa, and Asia-Pacific that inform tailored commercialization and regulatory approaches

Regional dynamics materially influence adoption patterns, regulatory pathways, and commercial approaches across the Americas, Europe Middle East & Africa, and Asia-Pacific. In the Americas, healthcare systems exhibit a strong appetite for advanced diagnostic capabilities and software-driven efficiency gains, supported by consolidated hospital networks and growing investment in outpatient and ambulatory care sites. This environment favors integrated solutions that demonstrate clinical impact and operational savings, while reimbursement dynamics and regulatory considerations guide the pace of adoption.

Europe Middle East & Africa presents a heterogeneous landscape where regulatory stringency, national health priorities, and infrastructure variability shape market entry strategies. Some markets emphasize centralized, high-quality imaging centers and national screening programs, prompting demand for scalable, interoperable solutions. Other markets are investing in capacity expansion and modernization, creating opportunities for modular systems and remote service offerings. Asia-Pacific is characterized by rapid expansion of diagnostic infrastructure, investments in local manufacturing, and strong interest in cost-effective, high-throughput technologies. Private healthcare growth and public initiatives to improve access to diagnostics are driving demand for both high-end modalities and portable point-of-care devices. Across regions, localization of service networks, compliance with regional regulatory frameworks, and culturally informed clinical validation are essential for successful commercialization. Understanding these regional distinctions enables targeted resource allocation and partnership selection to accelerate market penetration.

Competitive and collaborative company trends that reveal how incumbents, innovators, and software specialists are aligning through partnerships, M&A, and evidence generation to win in bio-imaging

Competitive dynamics in bio-imaging are shaped by a mix of legacy multinationals, nimble device innovators, and specialist software vendors. Legacy manufacturers retain strengths in scale, installed base service networks, and regulatory experience, which support large capital sales and long-term service agreements. At the same time, smaller firms and startups are rapidly introducing disruptive capabilities in image analysis, cloud-native data management, and point-of-care devices, prompting partnerships, licensing agreements, and targeted acquisitions to accelerate capability build-out.

Strategic collaborations between device OEMs and software companies are becoming more commonplace as hardware vendors seek to bundle analytic and data services that demonstrate measurable clinical value. Partnerships with academic medical centers and clinical research organizations are also essential for evidence generation and regulatory submissions. Moreover, companies that invest in robust post-market surveillance, cyber-security safeguards, and interoperability standards position themselves favorably with health systems that require secure, auditable data flows. The competitive landscape rewards firms that can integrate clinical validation, regulatory strategy, and go-to-market agility into a cohesive commercialization plan.

Actionable strategic guidance for leaders to enhance supply chain resilience, accelerate validated AI adoption, and align modular commercialization with regional market realities

Industry leaders should pursue a set of coordinated actions to translate technological promise into sustainable commercial advantage. First, diversify supply chains and qualify multi-regional manufacturing partners to reduce exposure to trade policy volatility and critical component shortages. Second, prioritize modular product design and services that enable faster upgrades, easier maintenance, and varied financing models adapted to ambulatory, diagnostic center, and hospital procurement preferences. Third, accelerate investment in validated AI and analytics, focusing on explainability, clinical validation, and regulatory alignment to build clinician trust and payer acceptance.

In parallel, strengthen strategic partnerships with software vendors, academic centers, and specialty service providers to co-develop evidence that links imaging outputs to improved patient outcomes. Implement robust data governance, cybersecurity, and interoperability frameworks to facilitate multi-institutional collaboration and secure cloud deployments. Finally, align commercialization plans with regional nuances by tailoring product configurations, service models, and reimbursement strategies to local market realities. These actions collectively reduce execution risk, increase adoption velocity, and create defensible differentiation in a competitive landscape.

Rigorous multi-method research design combining primary interviews, secondary evidence synthesis, and iterative validation to ensure robust, actionable insights for stakeholders

The study synthesizes insights from a multi-method research approach combining qualitative and quantitative techniques. Primary research consisted of structured interviews and scenario workshops with clinical leaders, procurement officers, technology executives, and regulatory specialists to surface pain points, adoption drivers, and commercial priorities. Secondary research involved a systematic review of peer-reviewed literature, regulatory filings, clinical guidelines, and technical whitepapers to contextualize technological trends and evidence requirements.

Data triangulation was used to reconcile insights across sources, while thematic analysis highlighted recurring adoption barriers and success factors. Validation exercises with external experts and iterative feedback loops ensured that conclusions reflect practical realities encountered by field stakeholders. Methodological rigor was maintained through transparent documentation of data sources, interview frameworks, and assumption checks, enabling reproducibility and confidence in the study's recommendations. Ethical considerations and confidentiality protocols were observed during primary engagements to protect proprietary information shared by participants.

Concise synthesis of how integrated technology, validated evidence, and regionally informed strategy will determine who captures value as bio-imaging transforms clinical care and research

In summary, bio-imaging stands at an inflection point where technological sophistication must be matched by pragmatic commercialization strategies. The convergence of advanced modalities, AI-enabled analytics, and cloud-native data architectures is unlocking new clinical capabilities while simultaneously raising expectations for evidence, interoperability, and data stewardship. Regulatory complexity and geopolitical trade dynamics add layers of strategic consideration, compelling organizations to adapt supply chains, accelerate clinical validation, and refine commercial models.

Decision-makers who act decisively to integrate validated software, modular hardware, and regionally attuned service models will be best positioned to capture value. Equally important is the ability to demonstrate measurable clinical and economic impact, which increasingly governs adoption and reimbursement. By aligning innovation road maps with clinician workflows, payer priorities, and regional regulatory contexts, stakeholders can convert technical advances into scalable clinical solutions that improve outcomes and operational efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of artificial intelligence powered algorithms in high throughput bio imaging workflows
  • 5.2. Rise of multimodal PET MRI imaging platforms enabling comprehensive molecular diagnostics
  • 5.3. Advancement of super resolution microscopy techniques for real time live cell imaging applications
  • 5.4. Emergence of cloud based bio imaging data management solutions for scalable research collaboration
  • 5.5. Growth of label free optical imaging modalities enhancing rapid tissue characterization workflows
  • 5.6. Development of theranostic contrast agents for simultaneous imaging and targeted drug delivery
  • 5.7. Integration of microfluidic lab on a chip systems with high resolution fluorescence microscopy
  • 5.8. Adoption of digital pathology and whole slide imaging for accelerated cancer diagnostics and analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Bio-imaging Market, by Technology

  • 8.1. Endoscopy
  • 8.2. Magnetic Resonance Imaging
  • 8.3. Nuclear Imaging
  • 8.4. Surgical Microscopy
  • 8.5. Ultrasound
  • 8.6. X-ray Imaging

9. Bio-imaging Market, by Product

  • 9.1. Imaging Systems
  • 9.2. Instruments
    • 9.2.1. CT Scanners
    • 9.2.2. MRI Machines
    • 9.2.3. Ultrasound Devices
  • 9.3. Reagents
  • 9.4. Software
    • 9.4.1. Data Management Software
    • 9.4.2. Image Analysis Software

10. Bio-imaging Market, by Modality

  • 10.1. 2D Imaging
  • 10.2. 3D Imaging

11. Bio-imaging Market, by Application

  • 11.1. Clinical Diagnostics
  • 11.2. Drug Discovery
  • 11.3. Research
  • 11.4. Therapeutics

12. Bio-imaging Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Diagnostic Imaging Centers
  • 12.3. Hospitals & Clinics

13. Bio-imaging Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Bio-imaging Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Bio-imaging Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. BaySpec, Inc.
    • 16.3.2. Bracco S.p.A.
    • 16.3.3. Bruker Corporation
    • 16.3.4. Canon Medical Systems Corporation
    • 16.3.5. Digirad Corporation
    • 16.3.6. Esaote S.p.A
    • 16.3.7. Fujifilm Holdings Corporation
    • 16.3.8. GE HealthCare Technologies, Inc.
    • 16.3.9. Hitachi Medical Corporation
    • 16.3.10. HT BioImaging Ltd
    • 16.3.11. iThera Medical GmbH
    • 16.3.12. Kitware, Inc.
    • 16.3.13. Koninklijke Philips N.V.
    • 16.3.14. Lantheus Medical Imaging, Inc.
    • 16.3.15. M Squared Lasers Ltd.
    • 16.3.16. MARS Bioimaging Limited
    • 16.3.17. Medtronic PLC
    • 16.3.18. MobileODT Ltd by Liger Medical LLC
    • 16.3.19. Perspectum Ltd.
    • 16.3.20. Quibim, S.L.
    • 16.3.21. RadNet, Inc.
    • 16.3.22. Rivanna Medical, Inc.
    • 16.3.23. Samsung Medison Co., Ltd.
    • 16.3.24. Siemens Healthineers

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BIO-IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BIO-IMAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BIO-IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BIO-IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BIO-IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIO-IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIO-IMAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIO-IMAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIO-IMAGING MARKET SIZE, BY ENDOSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIO-IMAGING MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIO-IMAGING MARKET SIZE, BY NUCLEAR IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIO-IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIO-IMAGING MARKET SIZE, BY X-RAY IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIO-IMAGING MARKET SIZE, BY CT SCANNERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIO-IMAGING MARKET SIZE, BY MRI MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIO-IMAGING MARKET SIZE, BY ULTRASOUND DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIO-IMAGING MARKET SIZE, BY REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIO-IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIO-IMAGING MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIO-IMAGING MARKET SIZE, BY IMAGE ANALYSIS SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIO-IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIO-IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIO-IMAGING MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIO-IMAGING MARKET SIZE, BY DRUG DISCOVERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIO-IMAGING MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIO-IMAGING MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIO-IMAGING MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIO-IMAGING MARKET SIZE, BY DIAGNOSTIC IMAGING CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIO-IMAGING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIO-IMAGING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS BIO-IMAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS BIO-IMAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 177. AMERICAS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 178. AMERICAS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 179. AMERICAS BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 180. AMERICAS BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 192. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. NORTH AMERICA BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 205. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 206. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 208. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 210. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 212. LATIN AMERICA BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 233. EUROPE BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 234. EUROPE BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 235. EUROPE BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 236. EUROPE BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 237. EUROPE BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 238. EUROPE BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 239. EUROPE BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 240. EUROPE BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 241. EUROPE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. EUROPE BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. EUROPE BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. EUROPE BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 250. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 252. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 254. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 256. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 258. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 260. MIDDLE EAST BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 261. AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. AFRICA BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 264. AFRICA BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 265. AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 266. AFRICA BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 267. AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 268. AFRICA BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 269. AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 270. AFRICA BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 271. AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 272. AFRICA BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 273. AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 274. AFRICA BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 275. AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 276. AFRICA BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 277. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 280. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL BIO-IMAGING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL BIO-IMAGING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 295. ASEAN BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 296. ASEAN BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 297. ASEAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 298. ASEAN BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 299. ASEAN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 300. ASEAN BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 301. ASEAN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 302. ASEAN BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 303. ASEAN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 304. ASEAN BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 305. ASEAN BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 306. ASEAN BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 307. ASEAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. ASEAN BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 309. ASEAN BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 310. ASEAN BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 311. GCC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. GCC BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. GCC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 314. GCC BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 315. GCC BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 316. GCC BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 317. GCC BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 318. GCC BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 319. GCC BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 320. GCC BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 321. GCC BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 322. GCC BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 323. GCC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 324. GCC BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 325. GCC BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 326. GCC BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 328. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 329. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 330. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 331. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 332. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 333. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 334. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 335. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 336. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 337. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 338. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 339. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 340. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 341. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 342. EUROPEAN UNION BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 343. BRICS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 344. BRICS BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 345. BRICS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 346. BRICS BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 347. BRICS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 348. BRICS BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 349. BRICS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 350. BRICS BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 351. BRICS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 352. BRICS BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 353. BRICS BIO-IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 354. BRICS BIO-IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 355. BRICS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 356. BRICS BIO-IMAGING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 357. BRICS BIO-IMAGING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 358. BRICS BIO-IMAGING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 359. G7 BIO-IMAGING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 360. G7 BIO-IMAGING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 361. G7 BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 362. G7 BIO-IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 363. G7 BIO-IMAGING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 364. G7 BIO-IMAGING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 365. G7 BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 366. G7 BIO-IMAGING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 367. G7 BIO-IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD